Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Minocycline Hydrochloride Patent Expiration

Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc in its drug Minocin on Approved Prior to Jan 1, 1982. Other drugs containing Minocycline Hydrochloride are Zilxi, Amzeeq, Emrosi, Arestin, Minolira, Solodyn, Minocycline Hydrochloride, Ximino. 31 different companies have introduced drugs containing Minocycline Hydrochloride.


Minocycline Hydrochloride Patents

Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Emrosi US10905664 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Emrosi US11191740 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Emrosi US11364212 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Amzeeq US10398641 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Amzeeq US10849847 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Minolira US11103517 Pharmaceutical compositions for minocycline Apr 07, 2036 Epi Hlth
Minocin US11944634 Tetracycline compositions Oct 16, 2032 Rempex
Solodyn US9192615 Method for the treatment of acne and certain dosage forms thereof Nov 17, 2031 Bausch
Minocin US12161656 Tetracycline compositions May 12, 2031 Rempex
Minocin US9084802 Tetracycline compositions May 12, 2031 Rempex
Minocin US9278105 Tetracycline compositions May 12, 2031 Rempex
Amzeeq US10086080 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10137200 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US10517882 Method for healing of an infected acne lesion without scarring Oct 01, 2030 Journey
Amzeeq US10821187 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US9675700 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Zilxi US10322186 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US12138311 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US9675700 Topical tetracycline compositions Oct 01, 2030 Journey
Solodyn US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Solodyn US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Ximino US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Ximino US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Solodyn US7919483 Method for the treatment of acne Mar 07, 2027 Bausch
Ximino US7919483 Method for the treatment of acne Mar 07, 2027 Journey
Solodyn US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Bausch
Solodyn US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Bausch
Solodyn US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Bausch
Solodyn US8722650 Extended-release minocycline dosage forms Jun 24, 2025

(Expired)

 Bausch
Ximino US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Journey
Ximino US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Journey
Ximino US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

 Journey
Arestin US6682348 Dispensing apparatus and cartridge Mar 29, 2022

(Expired)

 Orapharma
Arestin US7699609 Dispensing apparatus and cartridge with deformable tip Mar 29, 2022

(Expired)

 Orapharma
Solodyn US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

 Bausch
Ximino US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

 Journey



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Minocycline Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Minocycline Hydrochloride.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 20 Feb, 2024 US8268804(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Jan, 2024 US8252776(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 20 Apr, 2023 US9192615
Payment of Maintenance Fee, 4th Yr, Small Entity 19 Dec, 2022 US10322186
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2022 US7919483(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Feb, 2022 US7790705(Litigated)
Recordation of Patent Grant Mailed
Critical
 16 Mar, 2021 US10946101
Patent Issue Date Used in PTA Calculation
Critical
 16 Mar, 2021 US10946101
Email Notification
Critical
 26 Feb, 2021 US10946101
Issue Notification Mailed
Critical
 24 Feb, 2021 US10946101


Minocycline Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Minocycline Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Minocycline Hydrochloride. The first generic version for Minocycline Hydrochloride was by Lederle Laboratories Div American Cyanamid Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Nexus Pharmaceuticals Llc and was approved on Oct 24, 2024.

Given below is the list of companies who have filed for Minocycline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 45MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 105MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 90MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 135MG BASE

(reference standard)

tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 65MG BASE

tablet, extended release Prescription ORAL AB Mar 16, 2018
EQ 115MG BASE

(reference standard)

tablet, extended release Prescription ORAL AB Mar 16, 2018
EQ 55MG BASE

tablet, extended release Prescription ORAL AB Dec 19, 2019





2. ALVOGEN

Alvogen Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. All of these versions come by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Discontinued ORAL N/A Jul 31, 1990
EQ 50MG BASE

capsule Discontinued ORAL N/A Aug 14, 1990
EQ 75MG BASE

capsule Discontinued ORAL N/A Sep 15, 1999


Manufacturing Plant Locations
New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country City Firm Name
United States
Morristown Alvogen, Inc





3. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Prescription ORAL AB Mar 11, 2008
EQ 100MG BASE

capsule Prescription ORAL AB Mar 11, 2008
EQ 50MG BASE

capsule Prescription ORAL AB Mar 11, 2008


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





4. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 11 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE

tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 135MG BASE

tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 90MG BASE

tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 105MG BASE

tablet, extended release Prescription ORAL AB Jun 13, 2016
EQ 80MG BASE

tablet, extended release Prescription ORAL AB Jun 13, 2016
EQ 65MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 115MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 55MG BASE

tablet, extended release Prescription ORAL AB Aug 21, 2019
EQ 50MG BASE

tablet Prescription ORAL AB May 1, 2020
EQ 75MG BASE

tablet Prescription ORAL AB May 1, 2020
EQ 100MG BASE

tablet Prescription ORAL AB May 1, 2020


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





5. BARR LABS INC

Barr Laboratories Inc has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 90MG BASE

tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 45MG BASE

tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 135MG BASE

tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 65MG BASE

tablet, extended release Discontinued ORAL N/A May 18, 2012
EQ 115MG BASE

tablet, extended release Discontinued ORAL N/A May 18, 2012
EQ 105MG BASE

tablet, extended release Discontinued ORAL N/A Apr 26, 2017
EQ 80MG BASE

tablet, extended release Discontinued ORAL N/A Apr 26, 2017





6. BEXIMCO PHARMS USA

Beximco Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB May 27, 2022
EQ 75MG BASE

tablet Prescription ORAL AB May 27, 2022
EQ 50MG BASE

tablet Prescription ORAL AB May 27, 2022





7. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Dec 26, 2007
EQ 100MG BASE

tablet Prescription ORAL AB Dec 26, 2007
EQ 75MG BASE

tablet Prescription ORAL AB Dec 26, 2007
EQ 135MG BASE

tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 55MG BASE

tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 45MG BASE

tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 90MG BASE

tablet, extended release Prescription ORAL AB Nov 30, 2011





8. IMPAX LABS

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Prescription ORAL AB Mar 23, 1999
EQ 100MG BASE

capsule Prescription ORAL AB Mar 23, 1999
EQ 75MG BASE

capsule Prescription ORAL AB Apr 18, 2001





9. IMPAX LABS INC

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE

tablet, extended release Discontinued ORAL N/A Feb 3, 2009
EQ 135MG BASE

tablet, extended release Discontinued ORAL N/A Feb 3, 2009
EQ 90MG BASE

tablet, extended release Discontinued ORAL N/A Feb 3, 2009





10. LEDERLE

Lederle Laboratories Div American Cyanamid Co has filed for 1 generic for Minocycline Hydrochloride. This eq 100mg base/vial version comes by the name MINOCIN. Given below are the details of the strengths of this generic introduced by Lederle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





11. MEDICIS

Medicis Pharmaceutical Corp has filed for 1 generic for Minocycline Hydrochloride. This eq 50mg base version comes by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Medicis.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Aug 14, 1990


Manufacturing Plant Locations
New

Medicis's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Medicis as present at those locations.

Country City Firm Name
United States
Scottsdale Medicis Aesthetics Inc.
Scottsdale Medicis Pharmaceutical Corp





12. NEXUS

Nexus Pharmaceuticals Llc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

injectable Prescription INJECTION AP Oct 24, 2024


Manufacturing Plant Locations
New

Nexus's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Nexus as present at those locations.

Country City Firm Name
United States
Le Roy Nexus Cooperative
Brownsdale Nexus Cooperative
Santa Fe Springs Nexus Foods, Inc.
Conger Nexus Cooperative
Cerritos Nexus Foods Inc
Lansing Nexus Cooperative
Lincolnshire Nexus Pharmaceuticals, LLC
Emmons Nexus Cooperative
Lenexa Nexus Medical LLC
Salt Lake City Nexus Spine, LLC
Bedford Park Nexus Distribution Corp.
Pleasant Prairie Nexus Pharmaceuticals Inc
Adams Nexus Cooperative
Bedford Park Nexus Distribution Corporation
Cottonwood Heights Nexus CMF, LLC
Rose Creek Nexus Cooperative
San Diego Nexus Dx, Inc
Alden Nexus Cooperative





13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG BASE

tablet, extended release Discontinued ORAL N/A Jul 20, 2010
EQ 90MG BASE

tablet, extended release Discontinued ORAL N/A Jul 20, 2010
EQ 45MG BASE

tablet, extended release Discontinued ORAL N/A Jul 20, 2010





14. RISING

Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 105MG BASE

tablet, extended release Discontinued ORAL N/A Aug 22, 2014
EQ 80MG BASE

tablet, extended release Discontinued ORAL N/A Aug 22, 2014
EQ 65MG BASE

tablet, extended release Discontinued ORAL N/A Jul 30, 2019
EQ 115MG BASE

tablet, extended release Discontinued ORAL N/A Jul 30, 2019
EQ 55MG BASE

tablet, extended release Discontinued ORAL N/A Aug 21, 2019


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Phoenix Rising Sun Farms Inc
Rising Sun Rising Sun Veterinary Clinic
Saddle Brook Rising Pharmaceuticals, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Fort Bragg Rising Tide Sea Vegetables
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





15. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 90MG BASE

tablet, extended release Prescription ORAL AB Aug 13, 2009
EQ 135MG BASE

tablet, extended release Prescription ORAL AB Aug 13, 2009
EQ 45MG BASE

tablet, extended release Prescription ORAL AB Aug 13, 2009


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





16. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet Prescription ORAL AB Apr 16, 2003
EQ 50MG BASE

tablet Prescription ORAL AB Apr 16, 2003
EQ 100MG BASE

(reference standard)

tablet Prescription ORAL AB Apr 16, 2003


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





17. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE

tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 105MG BASE

tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 135MG BASE

tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 45MG BASE

tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 65MG BASE

tablet, extended release Prescription ORAL AB Oct 7, 2022
EQ 115MG BASE

tablet, extended release Prescription ORAL AB Oct 7, 2022
EQ 55MG BASE

tablet, extended release Prescription ORAL AB Oct 7, 2022


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Halol Sun Pharmaceutical Industries Ltd.
Dadra Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd
Mohali Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Vadodara Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd.
Punjab Sun Pharmaceutical Industries, Inc.





18. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Prescription ORAL AB May 13, 2013
EQ 75MG BASE

capsule Prescription ORAL AB May 13, 2013
EQ 100MG BASE

capsule Prescription ORAL AB May 13, 2013





19. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE

tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 105MG BASE

tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 45MG BASE

tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 135MG BASE

tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 90MG BASE

tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 65MG BASE

tablet, extended release Discontinued ORAL N/A Dec 3, 2019
EQ 115MG BASE

tablet, extended release Discontinued ORAL N/A Dec 3, 2019





20. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Discontinued ORAL N/A Jan 29, 2016
EQ 100MG BASE

tablet Discontinued ORAL N/A Jan 29, 2016
EQ 75MG BASE

tablet Discontinued ORAL N/A Jan 29, 2016





21. TORRENT

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Jan 6, 2004
EQ 100MG BASE

tablet Prescription ORAL AB Jan 6, 2004
EQ 75MG BASE

tablet Prescription ORAL AB Jan 6, 2004


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Pithampur Torrent Pharmaceuticals Limited
Bharuch Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.





22. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Prescription ORAL AB Dec 30, 1991
EQ 75MG BASE

capsule Prescription ORAL AB Jun 10, 1999





23. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Prescription ORAL AB Dec 30, 1991





24. ZYDUS

Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

(reference standard)

capsule Prescription ORAL AB Mar 2, 1992
EQ 50MG BASE

capsule Prescription ORAL AB Mar 2, 1992
EQ 75MG BASE

capsule Prescription ORAL AB Aug 12, 2003


Manufacturing Plant Locations
New

Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.

Country City Firm Name
India
Jarod Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Matoda, Ahmedabad Zydus Animal Health and Investments Limited
Ankleshwar Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Matoda Zydus Hospira Oncology Private Ltd.
Moraiya, Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
United States
Pennington Zydus Pharmaceuticals (USA) Inc





25. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE

tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 90MG BASE

tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 105MG BASE

tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 80MG BASE

tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 135MG BASE

tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 65MG BASE

tablet, extended release Discontinued ORAL N/A Jun 16, 2023
EQ 115MG BASE

tablet, extended release Discontinued ORAL N/A Jun 16, 2023
EQ 55MG BASE

tablet, extended release Discontinued ORAL N/A Jun 16, 2023